XML 24 R31.htm IDEA: XBRL DOCUMENT v2.4.0.8
Equity (Details) (USD $)
9 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended 9 Months Ended
Sep. 30, 2014
Dec. 31, 2013
Sep. 30, 2014
Restricted Stock [Member]
Sep. 30, 2014
Warrant [Member]
Sep. 30, 2014
2012 Equity Incentive Plan [Member]
Restricted Stock [Member]
Sep. 30, 2013
2012 Equity Incentive Plan [Member]
Restricted Stock [Member]
Sep. 30, 2014
Stock Option Plan 2002 [Member]
Restricted Stock [Member]
Sep. 30, 2014
Michael D. West [Member]
Sep. 30, 2014
Michael D. West [Member]
Sep. 30, 2014
Robert W. Peabody [Member]
Sep. 30, 2014
Robert W. Peabody [Member]
Sep. 30, 2014
Asterias Biotherapeutics [Member]
Sep. 30, 2014
Series Preferred A Stock [Member]
Preferred Shares [Abstract]                          
Preferred shares, shares authorized (in shares) 2,000,000 2,000,000                      
Preferred shares outstanding (in shares) 70,000 0                     70,000
Preferred stock dividend rate (in hundredths)                         3.00%
Preferred share dividend (in dollars per shares)                         $ 1.50
Share conversion price (in dollars per share)                         $ 4.00
Common stock conversion ratio                         12.5
Common Shares [Abstract]                          
Common shares, authorized (in shares) 125,000,000 125,000,000                      
Common shares, par value (in dollars per share) $ 0 $ 0                      
Common shares, shares issued (in shares) 73,690,302 67,412,139                      
Common shares, shares outstanding (in shares) 68,291,760 56,714,424                      
Treasury stock (in shares) 5,398,542 10,697,715                      
Number of Shares Authorized (in shares)     4,000,000 9,195,002                  
Stock options granted (in shares)         1,410,000 1,575,000              
Share options outstanding (in shares)             3,420,068            
Exercise price of warrant (in dollars per share)       $ 5.00               $ 5.00  
Number of warrants currently held to be distributed to holders of Series A Common Stock (in shares) 8,000,000                        
Options exercised (in shares) 2,060,400             1,470,400   475,000      
Options exercised (in dollars per share)                   $ 0.50      
Warrants exercised (in shares) 0                        
Market value of shares on option exercise date (in dollars per share) $ 2.65                        
Tax withholding obligation                 434,013   89,623